---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-078585"
form_type: "8-K/A"
ticker: "AVBP"
cik: "0001868279"
company_name: "ArriVent BioPharma, Inc."
filed_at: "2024-07-09T23:59:59+00:00"
generated_at: "2026-05-31T22:39:46.188218+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# ArriVent appoints Kristine Peterson to Board; she joins Compensation Committee

## Summary
- Kristine Peterson appointed as Class III director effective April 20, 2024, until 2027 annual meeting.
- Appointed to Compensation Committee on July 3, 2024.
- Received option grant with $352,500 fair value, vesting over three years; annual cash retainer of $45,000 prorated.
- Peterson brings >30 years biopharma experience; former CEO of Valeritas, exec roles at J&J and BMS.
- Currently on boards of Immunocore and Enanta; deemed independent under Nasdaq rules.

## SEC filing metadata
- accession: 0001104659-24-078585
- form_type: 8-K/A
- ticker: AVBP
- cik: 0001868279
- company_name: ArriVent BioPharma, Inc.
- filed_at: 2024-07-09T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1868279/000110465924078585/0001104659-24-078585-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1868279/000110465924078585/tm2419108-1_8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-078585
- JSON: https://secwatch.observer/filing/0001104659-24-078585.json
- Plain text: https://secwatch.observer/filing/0001104659-24-078585.txt

## Key facts
- Executive change
  Kristine Peterson was appointed as Director at ArriVent BioPharma, Inc..
  - Action: appointed
  - Role: Director
  source text: On April 20, 2024, the Board of Directors (the “Board”) of ArriVent BioPharma, Inc. (the “Company”) appointed Kristine Peterson to the Board, effective immediately (the “Effective Date”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1868279/000110465924078585/0001104659-24-078585-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.